Immunization of children receiving immunosuppressive therapy for cancer or hematopoietic stem cell transplantation

Ochsner Journal

Volumn 12, Issue 3, 2012, Pages 228-243

  Shetty, Avinash K ^a   Winter, Mary A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Hematopoietic stem cell transplantation; Immunization; Immunocompromised children; Vaccines

Indexed keywords

ABATACEPT; CALCINEURIN INHIBITOR; CHICKENPOX VACCINE; CORTICOSTEROID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOMODULATING AGENT; JAPANESE ENCEPHALITIS VACCINE; NATALIZUMAB; ORAL POLIOMYELITIS VACCINE; PALIVIZUMAB; RITUXIMAB; TUMOR NECROSIS FACTOR INHIBITOR;

ACTIVE IMMUNIZATION; ANTIBODY DETECTION; ANTIBODY RESPONSE; CANCER IMMUNIZATION; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CHICKENPOX; CHRONIC GRAFT VERSUS HOST DISEASE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HEALTH CARE PERSONNEL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOCOMPETENCE; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; MEMORY T LYMPHOCYTE; NATURAL KILLER CELL; OPPORTUNISTIC INFECTION; PASSIVE IMMUNIZATION; POLIOMYELITIS; PRACTICE GUIDELINE; REVIEW; SEASONAL INFLUENZA; SURVIVAL RATE; T LYMPHOCYTE;

EID: 84866519295     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (111)

1. Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007 Nov 14;298(18):2155-2163.
2. Esposito S, Cecinati V, Brescia L, Principi N. Vaccinations in children with cancer. Vaccine. 2010 Apr 26;28(19):3278-3284. Epub 2010 Mar 10.
3. Ruggiero A, Battista A, Coccia P, Attinà G, Riccardi R. How to manage vaccinations in children with cancer. Pediatr Blood Cancer. 2011 Dec 15;57(7):1104-1108. Epub 2011 Sep 23
4. Allen UD. Immunizations for children with cancer. Pediatr Blood Cancer. 2007 Dec;49(7 Suppl):1102-1108.
5. Abzug MJ. Vaccination in the immunocompromised child: a probe of immune reconstitution. Pediatr Infect Dis J. 2009 Mar; 28(3):233-236.
6. Ljungman P, Cordonnier C, Einsele H, et al; Center for International Blood and Marrow Transplant Research; National Marrow Donor Program; European Blood and Marrow Transplant Group; American Society of Blood and Marrow Transplantation; Canadian Blood and Marrow Transplant Group; Infectious Disease Society of America; Society for Healthcare Epidemiology of America; Association of Medical Microbiology and Infectious Diseases Canada; Centers for Disease Control and Prevention. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant. 2009 Oct;44(8):521-526.
7. Nield LS, Troisch MJ, Kamat D. Vaccinating the immunocompromised child. Consultant for Pediatricians. 2009; 8(Suppl):S7-S14.
8. Tamma P. Vaccines in immunocompromised patients. Pediatr Rev. 2010 Jan;31(1):38-40.
9. Pickering LK, Baker CJ, Freed GL, et al; Infectious Diseases Society of America. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2009 Sep 15;49(6):817-840. Erratum in: Clin Infect Dis. 2009 Nov 1;49(9): 1465.
10. Pirofski LA, Casadevall A. Use of licensed vaccines for active immunization of the immunocompromised host. Clin Microbiol Rev. 1998 Jan;11(1):1-26.
11. Moss W, Lederman H. Immunization of the immunocompromised host. Clin Focus Prim Immune Defic. 1998 Oct;1(1):1-8.
12. Burroughs M, Moscona A. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis. 2000 Jun; 30(6):857-869. Epub 2000 Jun 13.
13. Ljungman P. Vaccination of the immunocompromised host. In: Plotkin SA, Offit PA, Orenstein WA, eds Vaccines. Philadelphia, PA: WB Saunders; 2008:98-110.
14. Centers for Disease Control. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence. MMWR. 1993 April 9:42(RR-04):1-18.
15. Bodey GP. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years. J Antimicrob Chemother. 2009 May;63 Suppl 1:i3-i13.
16. Pui CH, Campana D, Pei D, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009 Jun 25;360(26):2730-2741.
17. Rubnitz JE, Inaba H, Dahl G, et al. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol. 2010 Jun;11(6): 543-552. Epub 2010 May 5.
18. Brady MT, Oleske JM, Williams PL, et al; Pediatric AIDS Clinical Trials Group 219/219C Team. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr. 2010 Jan;53(1):86-94.
19. Mofenson LM, Brady MT, Danner SP, et al; Centers for Disease Control and Prevention; National Institutes of Health; HIV Medicine Association of the Infectious Diseases Society of America; Pediatric Infectious Diseases Society; American Academy of Pediatrics. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166.
20. American Academy of Pediatrics. Immunization in special clinical circumstances. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:68-104.
21. Mackall CL, Fleisher TA, Brown MR, et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood. 1994 Oct 1;84(7):2221-2228.
22. Hersh EM, Whitecar JP Jr, McCredie KB, Bodey GP Sr, Freireich EJ. Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. N Engl J Med. 1971 Nov; 285(22):1211-1216.
23. Nilsson A, De Milito A, Engström P, et al. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Pediatrics. 2002 Jun;109(6):e91.
24. Mackall CL. T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review. Stem Cells. 2000;18(1):10-18.
25. Mustafa MM, Buchanan GR, Winick NJ, et al. Immune recovery in children with malignancy after cessation of chemotherapy. J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):451-457.
26. Kosmidis S, Baka M, Bouhoutsou D, et al. Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL. Pediatr Blood Cancer. 2008 Mar;50(3):528-532.
27. Alanko S, Salmi TT, Pelliniemi TT. Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1994 May-Jun;11(3):281-292.
28. Haining WN, Neuberg DS, Keczkemethy HL, et al. Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia. Blood. 2005 Sep 1;106(5):1749-1754. Epub 2005 May 26.
29. Aquino VM, Douek DC, Berryman B, Johnson M, Jain VK, Collins RH. Evaluation of thymic output by measurement of T-cell-receptor gene rearrangement excisional circles (TREC) in patients who have received fludarabine. Leuk Lymphoma. 2003 Feb; 44(2):343-348.
30. Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4{thorn} T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med. 1995 Jan 19;332(3):143-149.
31. Eyrich M, Wiegering V, Lim A, Schrauder A, Winkler B, Schlegel PG. Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia-a prospective study of 20 paediatric patients. Br J Haematol. 2009 Nov;147(3): 360-370. Epub 2009 Aug 19.
32. Löbermann M, Boršo D, Hilgendorf I, Fritzsche C, Zettl UK, Reisinger EC. Immunization in the adult immunocompromised host. Autoimmun Rev. 2012 Jan;11(3):212-218. Epub 2011 May 18.
33. Hilgendorf I, Freund M, Jilg W, et al. Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD. Vaccine. 2011 Apr 5;29(16):2825-2833. Epub 2011 Feb 20.
34. Wingard JR, Hsu J, Hiemenz JW. Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology. Infect Dis Clin North Am. 2010 Jun;24(2):257-272.
35. Gangappa S, Kokko KE, Carlson LM, et al. Immune responsiveness and protective immunity after transplantation. Transpl Int. 2008 Apr;21(4):293-303. Epub 2008 Jan 21.
36. Parkkali T, Käyhty H, Ruutu T, Volin L, Eskola J, Ruutu P. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT. Bone Marrow Transplant. 1996 Nov;18(5):961-967.
37. Lortan JE, Vellodi A, Jurges ES, Hugh-Jones K. Class-and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation. Clin Exp Immunol. 1992 Jun;88(3):512-519.
38. Hammarström V, Pauksen K, Azinge J, Oberg G, Ljungman P. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction. Support Care Cancer. 1993 Jul;1(4):195-199.
39. Cordonnier C, Labopin M, Chesnel V, et al. Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial. Vaccine. 2010 Mar 24;28(15):2730-2734. Epub 2010 Jan 29.
40. Meisel R, Kuypers L, Dirksen U, et al; Impfung von Kindern nach allogener Stammzelltransplantation (IKAST) Study Group. Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation. Blood. 2007 Mar 15;109(6):2322-2236. Epub 2006 Nov 7.
41. Zignol M, Peracchi M, Tridello G, et al. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Cancer. 2004 Aug 1; 101(3):635-641.
42. Feldman S, Andrew M, Norris M, McIntyre B, Iyer R. Decline in rates of seropositivity for measles, mumps, and rubella antibodies among previously immunized children treated for acute leukemia. Clin Infect Dis. 1998 Aug;27(2):388-390.
43. Fioredda F, Plebani A, Hanau G, et al. Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy. Eur J Haematol. 2005 Jan;74(1):20-23.
44. Patel SR, Ortin M, Cohen BJ, et al. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis. 2007 Mar 1;44(5):635-642. Epub 2007 Jan 24.
45. Patel SR, Chisholm JC, Heath PT. Vaccinations in children treated with standard-dose cancer therapy or hematopoietic stem cell transplantation. Pediatr Clin North Am. 2008 Feb;55(1):169-186.
46. Succi RC, Farhat CK. Vaccination in special situations. J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S91-S100. Epub 2006 May 4.
47. American Academy of Pediatrics. Poliovirus infections. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009: 541-545.
48. Nkowane BM, Wassilak SG, Orenstein WA, et al. Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA. 1987 Mar 13;257(10):1335-1340.
49. Leung TF, Chik KW, Li CK, et al. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant. 2000 Jan;25(2):167-172.
50. Levin MJ. Varicella vaccination of immunocompromised children. J Infect Dis. 2008 Mar 1;197 Suppl 2:S200-S206.
51. American Academy of Pediatrics. Varicella-zoster infections. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009: 714-727.
52. Sauerbrei A, Prager J, Hengst U, Zintl F, Wutzler P. Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplant. 1997 Sep;20(5):381-383.
53. Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA. 1992 Mar 4;267(9): 1237-1241.
54. Bakshi N, Lawson J, Hanson R, Ames C, Vinters HV. Fatal mumps meningoencephalitis in a child with severe combined immunodeficiency after bone marrow transplantation. J Child Neurol. 1996 Mar;11(2):159-162.
55. American Academy of Pediatrics. Measles. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:444-455.
56. Ercan TE, Soycan LY, Apak H, et al. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubella vaccination in children treated for acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2005 May;27(5):273-277.
57. Luthy KE, Tiedeman ME, Beckstrand RL, Mills DA. Safety of live-virus vaccines for children with immune deficiency. J Am Acad Nurse Pract. 2006 Oct;18(10):494-503.
58. King SM, Saunders EF, Petric M, Gold R. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. Bone Marrow Transplant. 1996 Apr;17(4):633-636.
59. Centers for Disease Control and Prevention (CDC). Addition of severe combined immunodeficiency as a contraindication for administration of rotavirus vaccine. MMWR Morb Mortal Wkly Rep. 2010 Jun 11;59(22):687-688.
60. Pérez-Schael I, Guntiñas MJ, Pérez M, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med. 1997 Oct 23;337(17):1181-1187. Erratum in: N Engl J Med. 1998 Apr 2;338(14):1002.
61. American Academy of Pediatrics. Tuberculosis. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:680-701.
62. Hesseling AC, Johnson LF, Jaspan H, et al. Disseminated bacilli Calmette-Guérin disease in HIV-infected South African infants. Bull World Health Organ. 2009 Jul;87(7):505-511.
63. Kwon HJ, Lee JW, Chung NG, Cho B, Kim HK, Kang JH. Assessment of serologic immunity to diphtheria-tetanus-pertussis after treatment of Korean pediatric hematology and oncology patients. J Korean Med Sci. 2012 Jan;27(1):78-83. Epub 2011 Dec 19.
64. Kung FH, Orgel HA, Wallace WW, Hamburger RN. Antibody production following immunization with diphtheria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease. Pediatrics. 1984 Jul;74(1):86-89.
65. Ridgway D, Wolff LJ, Deforest A. Immunization response varies with intensity of acute lymphoblastic leukemia therapy. Am J Dis Child. 1991 Aug;145(8):887-891.
66. Zengin E, Sarper N. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination. Pediatr Blood Cancer. 2009 Dec;53(6):967-972.
67. Vance E, George S, Guinan EC, et al. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Bone Marrow Transplant. 1998 Oct;22(8):735-741.
68. Small TN, Zelenetz AD, Noy A, et al. Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2009 Dec;15(12): 1538-1542. Epub 2009 Sep 25.
69. American Academy of Pediatrics. Haemophilus influenza infections. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:314-321.
70. Avanzini MA, Carrà AM, Maccario R, et al. Immunization with Haemophilus influenzae type b conjugate vaccine in children given bone marrow transplantation: comparison with healthy age-matched controls. J Clin Immunol. 1998 May;18(3):193-201.
71. Lee AC, Lam SY. Life threatening acute epiglottitis in acute leukemia. Leuk Lymphoma. 2002 Mar;43(3):665-667.
72. Rolston KV. The spectrum of pulmonary infections in cancer patients. Curr Opin Oncol. 2001 Jul;13(4):218-223.
73. Ek T, Mellander L, Hahn-Zoric M, Abrahamsson J. Intensive treatment for childhood acute lymphoblastic leukemia reduces immune responses to diphtheria, tetanus, and Haemophilus influenzae type b. J Pediatr Hematol Oncol. 2004 Nov;26(11): 727-734.
74. Ek T, Mellander L, Hahn-Zoric M, Abrahamsson J. Avidity of tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia-implications for vaccination strategies. Acta Paediatr. 2006 Jun;95(6):701-706.
75. McFarlane ES, Embil JA. Prevalence of antibodies to Hepatitis A antigen in sera from patients with haematological malignancies. J Med Virol. 1981;8(1):49-53.
76. Takai S, Tsurumi H, Ando K, et al. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol. 2005 Feb;74(2):158-165.
77. Köksal Y, Varan A, Aydin GB, et al. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer. Pediatr Hematol Oncol. 2007 Dec;24(8):587-594.
78. American Academy of Pediatrics. Hepatitis B. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:337-356.
79. American Academy of Pediatrics. Pneumococcal infections. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:524-535.
80. Kumar D, Humar A, Plevneshi A, et al; Toronto Invasive Bacterial Diseases Network. Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant. 2008 Apr;41(8):743-747. Epub 2008 Jan 7.
81. O'Brien KL, Hochman M, Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? Lancet Infect Dis. 2007 Sep;7(9): 597-606.
82. Chan CY, Molrine DC, George S, et al. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease. J Infect Dis. 1996 Jan;173(1):256-258.
83. Cordonnier C, Labopin M, Chesnel V, et al. Influence of immunization timing on the response to conjugate-pneumococcal vaccine after allogenic stem cell transplant: final results of the EBMT IDWP01 Trial. Bone Marrow Transplant. 2008 Mar:41(Suppl 1):S2.
84. Kumar D, Chen MH, Welsh B, et al. A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. Clin Infect Dis. 2007 Dec 15; 45(12):1576-1582.
85. Molrine DC, Antin JH, Guinan EC, et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood. 2003 Feb 1;101(3):831-836. Epub 2002 Sep 19.
86. American Academy of Pediatrics. Meningococcal infections. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:455-463.
87. Yu JW, Borkowski A, Danzig L, Reiter S, Kavan P, Mazer BD. Immune response to conjugated meningococcal C vaccine in pediatric oncology patients. Pediatr Blood Cancer. 2007 Dec; 49(7):918-923.
88. Parkkali T, Käyhty H, Lehtonen H, et al. Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients. Bone Marrow Transplant. 2001 Jan; 27(1):79-84.
89. Mahler MB, Taur Y, Jean R, Kernan NA, Prockop SE, Small TN. Safety and immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012 Jan;18(1):145-149. Epub 2011 Aug 4.
90. van Tilburg CM, Sanders EA, Rovers MM, Wolfs TF, Bierings MB. Loss of antibodies and response to (re-)vaccination in children after treatment for acute lymphocytic leukemia: a systematic review. Leukemia. 2006 Oct;20(10):1717-1722. Epub 2006 Aug 3.
91. Avery RK, Michaels M. Update on immunizations in solid organ transplant recipients: what clinicians need to know. Am J Transplant. 2008 Jan;8(1):9-14. Epub 2007 Dec 18.
92. American Academy of Pediatrics. Human papillomaviruses. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009: 477-483.
93. Principi N, Esposito S. Are we ready for universal influenza vaccination in paediatrics? Lancet Infect Dis. 2004 Feb;4(2):75-83.
94. Esposito S, Marchisio P, Principi N. The global state of influenza in children. Pediatr Infect Dis J. 2008 Nov;27(11 Suppl):S149-S153.
95. Hakim H, Allison KJ, Van De Velde LA, Li Y, Flynn PM, McCullers JA. Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults. Vaccine. 2012 Jan 20;30(5):879-885. Epub 2011 Dec 9.
96. Porter CC, Edwards KM, Zhu Y, Frangoul H. Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2004 Jan;42(1):36-40.
97. Matsuzaki A, Suminoe A, Koga Y, Kinukawa N, Kusuhara K, Hara T. Immune response after influenza vaccination in children with cancer. Pediatr Blood Cancer. 2005 Nov;45(6):831-837.
98. Esposito S, Cecinati V, Russo FG, Principi N. Influenza vaccination in children with cancer receiving chemotherapy. Hum Vaccin. 2009 Jun;5(6):430-432. Epub 2009 Jun 26.
99. Cecinati V, Esposito S, Scicchitano B, et al. Effectiveness of recall systems for improving influenza vaccination coverage in children with oncohematological malignancies. Hum Vaccin. 2010 Feb 6;6(2):194-197.
100. Goossen GM, Kremer LC, van de Wetering MD. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database Syst Rev. 2009 Apr 15;(2): CD006484.
101. American Academy of Pediatrics. Passive immunization. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:55-67.
102. American Academy of Pediatrics. Respiratory syncytial virus. In: Pickering LK, Baker CJ, Kimberlin DW, et al, eds. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009: 560-569.
103. Abuali MM, Arnon R, Posada R. An update on immunizations before and after transplantation in the pediatric solid organ transplant recipient. Pediatr Transplant. 2011 Dec;15(8):770-777
104. Kotton CN. Vaccination and immunization against travel-related diseases in immunocompromised hosts. Expert Rev Vaccines. 2008 Jul;7(5):663-672.
105. Staples JE, Gershman M, Fischer M; Centers for Disease Control and Prevention (CDC). Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010 Jul 30;59(RR-7):1-27.
106. Fischer M, Lindsey N, Staples JE, Hills S; Centers for Disease Control and Prevention (CDC). Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010 Mar 12;59(RR-1): 1-32.
107. Kappagoda C, Shaw P, Burgess M, Botham S, Cramer L. Varicella vaccine in non-immune household contacts of children with cancer or leukaemia. J Paediatr Child Health. 1999 Aug; 35(4):341-345.
108. Healy CM, Pickering LK. How to communicate with vaccine-hesitant parents. Pediatrics. 2011 May;127 Suppl 1:S127-S133. Epub 2011 Apr 18.
109. Gust DA, Darling N, Kennedy A, Schwartz B. Parents with doubts about vaccines: which vaccines and reasons why. Pediatrics. 2008 Oct;122(4):718-725.
110. Freed GL, Clark SJ, Butchart AT, Singer DC, Davis MM. Sources and perceived credibility of vaccine-safety information for parents. Pediatrics. 2011 May;127 Suppl 1:S107-S112. Epub 2011 Apr 18.
111. Pineda D, Myers MG. Finding reliable information about vaccines. Pediatrics. 2011 May;127 Suppl 1:S134-S137. Epub 2011 Apr 18.